Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma

Korean Journal of Urology

Volumn 52, Issue 2, 2011, Pages 104-109

  Dae, Sung Cho ^a   Se, Joong Kim ^a   Soo, Hyung Lee ^a   Hyun, Soo Ahn ^a   Young, Soo Kim ^a   Sun, Il Kim ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

C reactive protein; Prognosis; Renal cell carcinoma; Thrombocytosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PREOPERATIVE PERIOD; RECURRENCE RISK; RECURRENT DISEASE; THROMBOCYTE; THROMBOCYTOSIS; TUMOR RECURRENCE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

EID: 79952493394     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2011.52.2.104     Document Type: Article

References (29)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
2. Gudbjartsson T, Thoroddsen A, Petursdottir V, Hardarson S, Magnusson J, Einarsson GV. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology 2005;66:1186-91. (Pubitemid 41797287)
3. Ljungberg B, Alamdari FI, Stenling R, Roos G. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 1999;36:565-9. (Pubitemid 29516286)
4. Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 1998;159:1163-7. (Pubitemid 28172785)
5. Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005;173:48-51. (Pubitemid 39627669)
6. Lee SE, Byun SS, Han JH, Han BK, Hong SK. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma. BJU Int 2006;98:1228-32. (Pubitemid 44721231)
7. Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer 2008;113:450-60.
8. Kwon WA, Park C, Kim EJ, Ha YS, Kim YJ, Yun SJ, et al. The relationship between RUNX3 inactivation and its pathological features in renal cell carcinoma. Korean J Urol 2009;50:432-8.
9. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
10. Casamassima A, Picciariello M, Quaranta M, Berardino R, Ranieri C, Paradiso A, et al. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy. J Urol 2005;173:52-5. (Pubitemid 39627670)
11. Mitus AJ, Schafer AI. Thrombocytosis and thrombocythemia. Hematol Oncol Clin North Am 1990;4:157-78. (Pubitemid 20095144)
12. Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 1996; 9:1826-30. (Pubitemid 26294751)
13. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002;9:287-91. (Pubitemid 34298634)
14. Göǧüş C, Baltaci S, Filiz E, Elhan A, Bedük Y. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma. Urology 2004;63:447-50.
15. Ito K, Asano T, Yoshii H, Satoh A, Sumitomo M, Hayakawa M. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma. Int J Urol 2006;13:1365-70. (Pubitemid 44657040)
16. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. American joint committee on cancer staging manual. 6th ed. New York: Springer-Verlag; 2002;323-8.
17. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63. (Pubitemid 13234762)
18. Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992;37:313-36.
19. Yoshida N, Ikemoto S, Narita K, Sugimura K, Wada S, Yasumoto R, et al. Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma. Br J Cancer 2002;86:1396-400. (Pubitemid 34548059)
20. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989;250:607-10. (Pubitemid 19171418)
21. Guillem P, Triboulet JP. Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus 2005;18:146-50. (Pubitemid 41801107)
22. Kodama J, Miyagi Y, Seki N, Tokumo K, Yoshinouchi M, Kobashi Y, et al. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999;82:107-10. (Pubitemid 29042226)
23. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998;176: 335-8. (Pubitemid 28514444)
24. Hwang IC, Chang SG. Clinical significance of serum C-reactive protein in patients with renal cell carcinoma. Korean J Urol 1999; 40:864-8.
25. Komai Y, Saito K, Sakai K, Morimoto S. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. BJU Int 2007;99:77-80. (Pubitemid 44915624)
26. Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, et al. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992;52:3317-22.
27. Ramakrishnan S, Xu FJ, Brandt SJ, Niedel JE, Bast RC Jr, Brown EL. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 1989;83:921-6. (Pubitemid 19080625)
28. Hollen CW, Henthorn J, Koziol JA, Burstein SA. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 1991;79:286-90.
29. Karakiewicz PI, Trinh QD, Lam JS, Tostain J, Pantuck AJ, Belldegrun AS, et al. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol 2007;52:1428-36.